Literature DB >> 23929799

Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques.

Martin Gotthardt1, Chantal P Bleeker-Rovers, Otto C Boerman, Wim J G Oyen.   

Abstract

Nuclear medicine imaging procedures play an important role in the assessment of inflammatory diseases. With the advent of 3-dimensional anatomic imaging, there has been a tendency to replace traditional planar scintigraphy by CT or MRI. Furthermore, scintigraphic techniques may have to be combined with other imaging modalities to achieve high sensitivity and specificity, and some may require time-consuming labeling procedures. On the other hand, new developments such as combined SPECT/CT increase the diagnostic power of scintigraphy. Also, the advent of PET had a considerable impact on the use of nuclear medicine imaging techniques. In this review, we aim to provide nuclear medicine specialists and clinicians with the relevant information on rational and efficient use of nuclear medicine imaging techniques in the assessment of patients with osteomyelitis, infected vascular prostheses, metastatic infectious disease, rheumatoid arthritis, vasculitis, inflammatory bowel disease, sarcoidosis, and fever of unknown origin.

Entities:  

Keywords:  PET; SPECT; infectious disease; inflammation; radionuclide imaging

Mesh:

Substances:

Year:  2013        PMID: 23929799     DOI: 10.2967/jnumed.110.076232

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  9 in total

1.  Detection of necrosis of the gastric fundus after blunt abdominal trauma by PET-CT.

Authors:  A Hofer; H Kratochwill; A Pentsch; M Gabriel
Journal:  Wien Klin Wochenschr       Date:  2014-11-25       Impact factor: 1.704

Review 2.  Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis.

Authors:  Fatemeh Khodadust; Aiarpi Ezdoglian; Maarten M Steinz; Judy R van Beijnum; Gerben J C Zwezerijnen; Gerrit Jansen; Sander W Tas; Conny J van der Laken
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

3.  Analysis of the clinical manifestations and 18F-FDG PET-CT findings in 40 patients with histiocytic necrotizing lymphadenitis.

Authors:  Rui Zhang; Lidan Liang; Daoming Li; Yuling Bai; Xiangzhou Li
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

4.  Growing applications of FDG PET-CT imaging in non-oncologic conditions.

Authors:  Hongming Zhuang; Ion Codreanu
Journal:  J Biomed Res       Date:  2015-03-08

Review 5.  Using Nuclear Medicine Imaging Wisely in Diagnosing Infectious Diseases.

Authors:  Andrea Censullo; Tara Vijayan
Journal:  Open Forum Infect Dis       Date:  2017-02-03       Impact factor: 3.835

6.  99mTc-HMPAO-leukocyte scintigraphy for diagnosis and therapy monitoring of skull base osteomyelitis.

Authors:  Laura Rozenblum-Beddok; Benjamin Verillaud; Frédéric Paycha; Pierre Vironneau; Mukedaisi Abulizi; Abdel Benada; Tumatarii Cross; Ghada El-Deeb; Nicolas Vodovar; Ilana Peretti; Philippe Herman; Laure Sarda-Mantel
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-05-14

7.  Preclinical Evaluation of a Novel 99mTc-Labeled CB86 for Rheumatoid Arthritis Imaging.

Authors:  Peng Liu; Tingting Wang; Rongshui Yang; Wentao Dong; Qiang Wang; Zhide Guo; Chao Ma; Weixing Wang; Huaibo Li; Xinhui Su
Journal:  ACS Omega       Date:  2020-11-30

8.  Fludeoxyglucose positron emission tomography-computed tomography scan showing polyarthritis in a patient with an atypical presentation of Henoch-Schönlein vasculitis without clinical signs of arthritis: a case report.

Authors:  Christiaan F Mooij; Rick Hermsen; Esther P A H Hoppenreijs; Chantal P Bleeker-Rovers; Marloes M IJland; Lioe-Fee de Geus-Oei
Journal:  J Med Case Rep       Date:  2016-06-02

9.  Common features of F-18 FDG PET/CT findings in Scrub Typhus: prospective study before and after antibiotics therapy.

Authors:  Joo-Hee Hwang; Yeon-Hee Han; Seung Hee Choi; Mir Jeon; Suhyun Kim; Yeon-Joon Kim; Chang-Seop Lee; Seok Tae Lim
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.